IP Library Granted Patent US 10,610,208
Granted Patent B2
US 10,610,208 · App. 14/864,697 · Granted Apr 7, 2020

Subxyphoid epicardial ablation

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,610,208
App. No.
14/864,697
Granted
Apr 7, 2020
Kind
B2
Abstract

Methods and devices described herein facilitate ablation patterns on the heart within a pericardial sac and without opening or deflating the lungs.

Claims (35)

1. A method of creating a lesion on a surface of a heart in a body of a patient, the method comprising:

creating an incision to access a chest cavity of the patient;

creating an opening in a pericardium of the patient and positioning an access device with a dilation device into the pericardial space;

creating a path within the pericardial space by positioning the dilation device within a desired location in the pericardial space prior to dilating the pericardium and subsequently dilating the pericardium at a plurality of locations such that the plurality of locations form the path;

advancing a treatment device through the path to position the treatment device against a surface of the heart; and

creating the lesion on the surface of the heart using the treatment device.

2. The method of claim 1 , further comprising advancing a guide wire into the pericardial space and where positioning the dilation device into the pericardial space comprises advancing the dilation device over the guidewire.

3. The method of claim 2 , further comprising withdrawing the dilation device from the guidewire, and where advancing the treatment device comprises advancing the treatment device over the guidewire.

4. The method of claim 2 , where the guidewire comprises a steerable guidewire, the method further comprising steering the guidewire to advance the guidewire.

5. The method of claim 1 , further comprising expanding the dilating device during creating of the lesion to separate an anatomical structure from the heart surface.

6. The method of claim 5 , where the anatomical structure comprises a structure selected from a phrenic nerve or an esophagus.

7. The method of claim 1 , further comprising cooling tissue using the dilation device before, during or after creating of the lesion.

8. The method of claim 1 , where the dilation device comprises a fluid expandable balloon.

9. The method of claim 1 , where the dilation device comprises a mechanically expandable structure.

10. The method of claim 1 , further comprising delivering a fluid to the pericardial space.

11. The method of claim 10 , where delivering the fluid to the pericardial space comprises maintaining a fluid layer between the heart surface and the pericardium.

12. The method of claim 11 , where maintaining the fluid layer between the heart surface and the pericardium comprises cooling the surface of the heart.

13. The method of claim 11 , further comprising advancing a visualization device into the fluid layer to maintain visualization of the surface of the heart during creating the lesion.

14. The method of claim 11 , further comprising delivering a contrast agent to the pericardial space.

15. The method of claim 11 , further comprising delivering a medicament substance to assist in healing of heart tissue.

16. The method of claim 1 , further comprising remotely tracking the dilation device to localize a position of the dilation device from outside the body of the patient.

17. The method of claim 1 , where the treatment device comprises a steering mechanism and where advancing the treatment device comprises steering the treatment device.

18. The method of claim 1 , further where the dilation device is coupled to the treatment device.

19. The method of claim 1 , further where the dilation device is coupled to a guidewire.

20. The method of claim 1 , where the treatment device comprises an opening exposing an electrode, the treatment device also comprising a vacuum lumen in fluid communication with a vacuum source and a fluid perfusion lumen fluid communication with a fluid source, where both the vacuum lumen and fluid perfusion lumen are fluidly coupled to the opening.

21. The method of claim 20 , further comprising drawing a vacuum in the vacuum source to cause a drop in pressure in both the vacuum lumen and the opening, whereupon placing the opening against a soft tissue of the surface of the heart creates a seal against the soft tissue to cause the fluid perfusion lumen to drop in pressure resulting in fluid flow from the fluid source through the fluid perfusion lumen across the opening and through the vacuum lumen, where when uncovered the opening prevents the perfusion lumen from reducing in pressure and preventing fluid flow.

22. The method of claim 20 , where creating the lesion on the surface of the heart comprises applying RF energy to using the electrode to create a contiguous transmural lesion in atrial tissue of the heart.

23. The method of claim 22 , where creating the contiguous transmural lesion comprises creating a series of contiguous transmural lesions.

24. The method of claim 22 , where advancing the treatment device comprises advancing the treatment device to a plurality of regions to create a pattern of lesions on the surface of the heart.

25. The method of claim 20 , where advancing the treatment device to the irregular surface of the soft tissue comprises advancing the treatment device during a procedure selected from the group consisting of an arthroscopic, laparoscopic, and other minimally invasive procedure.

26. The method of claim 20 , where creating the lesion on the surface of the heart comprises applying vibrational energy to the electrode to create a contiguous transmural lesion in atrial tissue.

27. The method of claim 20 , where the electrode has a length and conforms to the surface of the heart to create a curvilinear lesion.

28. The method of claim 20 , where the portion of the treatment device housing the electrode is pre-shapeable to assume a shape and where the lesion forms in the shape.

29. The method of claim 20 , further comprising advancing a track adjacent to the irregular surface and where advancing the treatment device to the irregular surface comprises advancing the treatment device over the track.

30. The method of claim 29 , where the track comprises a device selected from the group consisting of a wire, a steerable catheter, a steerable guide-wire, a shaped tube, and a shaped mandrel.

Assignments (6)
MERGER AND CHANGE OF NAME Recorded Jan 28, 2026
From: NCONTACT SURGICAL, INC.; SECOND PORTAL MERGER SUB, LLC
To: NCONTACT SURGICAL, LLC
Reel/Frame 073617/0340 →
RELEASE OF SECURITY INTEREST Recorded Jan 10, 2024
From: SILICON VALLEY BANK, A DIVISION OF FIRST-CITIZENS BANK & TRUST COMPANY
To: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC; SENTREHEART LLC
Reel/Frame 066256/0797 →
SECURITY INTEREST Recorded Jan 10, 2024
From: ATRICURE, INC.; ATRICURE, LLC.
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066267/0896 →
SECURITY INTEREST Recorded Dec 18, 2018
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 047951/0496 →
SECOND AMENDED AND RESTATED JOINT INTELLECTUAL PROPERTY SECURITY AGREEMENT Recorded Apr 25, 2016
From: ATRICURE, INC.; ATRICURE, LLC; ENDOSCOPIC TECHNOLOGIES, LLC; NCONTACT SURGICAL, LLC
To: SILICON VALLEY BANK
Reel/Frame 038520/0062 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 11, 2016
From: NCONTACT SURGICAL, LLC
To: ATRICURE, INC.
Reel/Frame 038062/0392 →